SCHEMBL599266

SCHEMBL599266

C[C@@H]1CC[C@H](c2noc(-c3ccc(F)cc3)n2)CN1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.50
GRM5 P41594 1/20 0.48
HCRTR1 O43613 7/20 0.46
HCRTR2 O43614 7/20 0.46
USP7 Q93009 2/20 0.46
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
HSD11B1 P28845 1/20 0.44
HTT P42858 2/20 0.43
POLB P06746 2/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
USP30 Q70CQ3 1/20 0.42
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL599267 1.00 IDO1 (0.50) IDO1GRM5HCRTR1HCRTR2USP7
SCHEMBL599268 1.00 IDO1 (0.50) IDO1GRM5HCRTR1HCRTR2USP7
SCHEMBL599430 0.89 HCRTR1 (0.49) IDO1GRM5HCRTR1HCRTR2USP7
SCHEMBL601360 0.89 HCRTR1 (0.49) IDO1GRM5HCRTR1HCRTR2USP7
SCHEMBL7879741 0.85 GRM5 (0.51) IDO1GRM5HCRTR1HCRTR2USP7
SCHEMBL600383 0.85 HCRTR1 (0.43) IDO1HCRTR1HCRTR2
SCHEMBL30794584 0.82 GRM5 (0.46) IDO1GRM5HCRTR1HCRTR2HSD11B1
SCHEMBL599401 0.82 GRM5 (0.46) IDO1GRM5HCRTR1HCRTR2HSD11B1
SCHEMBL10189494 0.79 HCRTR1 (0.47) HCRTR1HCRTR2
SCHEMBL601120 0.79 HCRTR1 (0.45) IDO1HCRTR1HCRTR2USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040998-A1 2-ALKYL PIPERIDINE MGLUR5 RECEPTOR MODULATORS MERCER SWATI P (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040998-A1 2-ALKYL PIPERIDINE MGLUR5 RECEPTOR MODULATORS GRM5, GRIK5, GRM2 IDO1 3079/4885GRM5 1/4885HCRTR1 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.